LIVE

AGGREGATED External reporting by CNBC. This page summarizes the publisher's feed entry; the full article is on www.cnbc.com.

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

CNBC ·

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

READ THE ORIGINAL AT CNBC ↗ MORE FROM THIS SOURCE

RELATED REPORTING